AstraZeneca vaccine: EMA says blood clots 'very rare' and age or gender not risk factor

EU regulators have insisted blood clots are a "very rare" side effect of the AstraZeneca vaccine and insisted the "benefits" outweigh the risk.

Who will be Next to leave the EU? Check out who is leading in our exclusive poll Poll